Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy

NANot yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

February 28, 2027

Conditions
Dual Use of Cigarettes and E-cigarettesGestational Weight GainBirth-weight-for-gestational-age z Score
Interventions
BEHAVIORAL

Simultaneous cessation intervention

This simultaneous cessation intervention group will target CCs and ECs at the same time. Participants in this group will receive a multi-component cessation intervention, including behavior counseling, biomarker feedback via monitoring changes in levels of exposure to nicotine (urine cotinine) and CC smoke (breath carbon monoxide), and contingent financial incentives for biochemically verified abstinence.

BEHAVIORAL

Stepwise cessation intervention

This stepwise cessation intervention group will first target CCs and then target ECs after quitting CCs. Participants in this group will receive a multi-component cessation intervention, including behavior counseling, biomarker feedback via monitoring changes in levels of exposure to nicotine (urine cotinine) and CC smoke (breath carbon monoxide), and contingent financial incentives for biochemically verified abstinence.

BEHAVIORAL

Behavior counseling only

Participants assigned to the control group will receive behavior counseling only. They will complete the same number of study visits as their counterparts in the intervention groups.

Trial Locations (1)

14214

State University of New York at Buffalo, Buffalo

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

State University of New York at Buffalo

OTHER

NCT07124702 - Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy | Biotech Hunter | Biotech Hunter